Target intelligence / Profile preview

RNA, U2 small nuclear 26, pseudogene (RNU2-26P)

Target: RNU2-26P
Molecular classification: Pseudogene, Small nuclear RNA, Non-coding RNA

Overview

RNA, U2 small nuclear 26, pseudogene (RNU2-26P) is a pseudogene closely related to small nuclear RNA (snRNA) genes of the U2 family. U2 snRNAs are components of the spliceosome involved in pre-mRNA splicing, but as RNU2-26P is classified as a pseudogene, it is considered non-functional and is not known to produce functional RNA or protein products[1][2][4]. There are no established biological functions, disease roles, or known drug interactions related to this pseudogene.

Other names: RNU2-26PRNA, U2 small nuclear 26, pseudogene

Beyond the preview

Go deeper on RNA, U2 small nuclear 26, pseudogene (RNU2-26P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U2 small nuclear 26, pseudogene (RNU2-26P).

Explore the full profile